Go Pro

Oculis (OCS) Institutional Ownership

Oculis logo
$13.01 +1.01 (+8.43%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Oculis (NASDAQ:OCS)

Current
Institutional Ownership
Percentage
22.30%
Number of
Institutional Buyers
(last 12 months)
25
Total
Institutional Inflows
(last 12 months)
$102.22M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$2.57M
Get OCS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oculis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OCS Institutional Buying and Selling by Quarter

Oculis Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE69,764$1.86M0.0%+9.1%0.120%
5/12/2026Himension Capital Singapore PTE. LTD.18,926$503K0.0%N/A0.033%
4/28/2026Koshinski Asset Management Inc.8,937$238K0.0%N/A0.015%
4/27/2026Simplify Asset Management Inc.66,667$1.77M0.0%-32.5%0.115%
4/27/2026Y Intercept Hong Kong Ltd29,197$776K0.0%N/A0.050%
2/18/2026Perceptive Advisors LLC493,827$9.86M0.2%N/A0.943%
2/18/2026Millennium Management LLC15,641$312K0.0%N/A0.030%
2/16/2026NEXTBio Capital Management LP149,750$2.99M1.8%N/A0.286%
2/13/2026Marshall Wace LLP45,773$914K0.0%N/A0.087%
2/13/2026Pivotal bioVenture Partners Investment Advisor LLC2,288,658$45.70M17.7%-0.5%4.369%
2/13/2026Alyeska Investment Group L.P.331,332$6.62M0.0%+152.3%0.633%
2/12/2026HRT Financial LP43,914$876K0.0%N/A0.084%
2/12/2026SR One Capital Management LP641,022$12.80M1.8%+98.8%1.224%
2/12/2026Renaissance Technologies LLC25,000$499K0.0%N/A0.048%
2/12/2026Alps Advisors Inc.46,947$938K0.0%N/A0.090%
2/12/2026Folketrygdfondet182,800$3.65M0.2%N/A0.349%
2/11/2026Propel Bio Management LLC172,839$3.45M2.9%N/A0.330%
2/9/2026Geode Capital Management LLC36,061$720K0.0%+22.5%0.069%
2/9/2026Simplify Asset Management Inc.98,765$1.97M0.0%N/A0.189%
2/2/2026Gildi lifeyrissjodur2,447,985$50.25M22.7%N/A4.674%
1/29/2026China Universal Asset Management Co. Ltd.2,000$40K0.0%+100.0%0.004%
1/16/2026Aberdeen Group plc1,746,946$34.89M0.1%+39.4%3.335%
1/16/2026Compagnie Lombard Odier SCmA107,300$2.14M0.0%+10.6%0.205%
1/13/2026Syquant Capital Sas192,722$3.85M0.5%N/A0.368%
1/7/2026Aventura Private Wealth LLC4,000$80K0.0%N/A0.008%
11/17/2025Woodline Partners LP83,833$1.47M0.0%+65.8%0.160%
11/17/2025Bank of America Corp DE38,535$677K0.0%-4.9%0.074%
11/14/2025Acuta Capital Partners LLC101,777$1.79M1.8%-4.6%0.194%
11/13/2025UBS Group AG74,732$1.31M0.0%-40.9%0.143%
8/15/2025Bellevue Group AG9,700$188K0.0%-31.2%0.022%
8/15/2025Bank of America Corp DE40,512$786K0.0%+2.2%0.093%
8/14/2025Acuta Capital Partners LLC106,718$2.07M2.9%-14.6%0.244%
8/13/2025Bosun Asset Management LLC19,472$378K0.1%N/A0.045%
8/13/2025Marshall Wace LLP20,253$393K0.0%N/A0.046%
8/8/2025Geode Capital Management LLC29,436$571K0.0%+27.7%0.067%
7/15/2025Compagnie Lombard Odier SCmA97,000$1.88M0.0%+11.5%0.222%
5/16/2025Alyeska Investment Group L.P.131,332$2.50M0.0%N/A0.301%
5/14/2025Pivotal bioVenture Partners Investment Advisor LLC2,300,774$43.78M35.4%+32.4%5.270%
5/13/2025SR One Capital Management LP322,500$6.14M1.6%N/A0.739%
5/13/2025Aberdeen Group plc1,253,119$23.85M0.0%+24.1%2.870%
SPCX Warning - and Worst News for Stocks in 50 Years (Ad)

Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits.tc pixel

Learn how to prepare your portfolio for what's coming next
5/5/2025Kestra Private Wealth Services LLC12,322$234K0.0%N/A0.028%
4/16/2025Compagnie Lombard Odier SCmA87,000$1.66M0.0%-9.1%0.199%
2/17/2025Citadel Advisors LLC22,911$389K0.0%N/A0.057%
2/17/2025Bank of America Corp DE28,980$493K0.0%+58.2%0.072%
2/17/2025Bellevue Group AG10,000$170K0.0%N/A0.025%
2/13/2025XTX Topco Ltd13,249$225K0.0%N/A0.033%
2/12/2025Geode Capital Management LLC16,744$284K0.0%+12.0%0.041%
1/24/2025abrdn plc1,009,424$17.15M0.0%+23.0%2.492%
10/25/2024abrdn plc820,553$10.06M0.0%-25.4%2.026%
5/14/2024Nan Fung Group Holdings Ltd436,378$5.26M4.9%-15.9%1.077%
2/14/2024Pivotal bioVenture Partners Investment Advisor LLC1,888,788$21.21M5.4%-14.9%5.190%
2/6/2024Searle & CO.10,000$112K0.0%N/A0.027%
1/31/2024abrdn plc1,452,741$15.98M0.0%N/A3.992%
1/16/2024Compagnie Lombard Odier SCmA95,750$1.05M0.0%+47.3%0.263%
11/14/2023Nan Fung Group Holdings Ltd606,684$6.67M5.4%-6.8%1.667%
11/14/2023Pivotal bioVenture Partners Investment Advisor LLC2,218,754$24.41M9.7%-6.8%6.097%
11/13/2023Wolverine Asset Management LLC7,021$77K0.0%N/A0.019%
9/21/2023Barclays PLC3,602$44K0.0%N/A0.010%
5/12/2023Nan Fung Group Holdings Ltd651,100$4.84M3.3%N/A1.989%
5/1/2023Compagnie Lombard Odier SCmA65,000$472K0.0%N/A0.199%


OCS Institutional Ownership - Frequently Asked Questions

During the previous two years, 33 institutional investors and hedge funds held shares of Oculis. The most heavily invested institutionals were Gildi lifeyrissjodur ($50.25M), Pivotal bioVenture Partners Investment Advisor LLC ($45.70M), Aberdeen Group plc ($34.89M), abrdn plc ($17.15M), SR One Capital Management LP ($12.80M), Perceptive Advisors LLC ($9.86M), and Alyeska Investment Group L.P. ($6.62M).Learn more on Oculis' institutional investors.

22.30% of Oculis' stock is owned by institutional investors. Learn more on OCS's institutional investor holdings.

Of the 31 institutional investors that purchased Oculis' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Gildi lifeyrissjodur ($2.45M), Aberdeen Group plc ($737.52K), SR One Capital Management LP ($641.02K), Pivotal bioVenture Partners Investment Advisor LLC ($563.08K), Perceptive Advisors LLC ($493.83K), Alyeska Investment Group L.P. ($331.33K), and Syquant Capital Sas ($192.72K).

Institutional investors have bought a total of 5,103,362 shares in the last 24 months. This purchase volume represents approximately $102.22M in transactions.

The following institutional investors have sold Oculis stock in the last 24 months: UBS Group AG ($51.78K), Simplify Asset Management Inc. ($32.10K), Acuta Capital Partners LLC ($23.22K), Pivotal bioVenture Partners Investment Advisor LLC ($12.12K), Bellevue Group AG ($4.40K), and Bank of America Corp DE ($1.98K).

Institutional investors have sold a total of 125,597 shares in the last 24 months. This volume of shares sold represents approximately $2.57M in transactions.



This page (NASDAQ:OCS) was last updated on 6/30/2026 by MarketBeat.com Staff.
From Our Partners